Novartis Sues To Reverse USPTO Judgment
A Novartis AG subsidiary has filed a federal lawsuit against two French research institutions, seeking to overturn an unfavorable judgment in a patent interference proceeding before a U.S. Patent and Trademark...To view the full article, register now.
Already a subscriber? Click here to view full article